What Is Your Compounding Pharmacy Actually Worth? A 2026 Valuation Guide

By SlimionRX Business Team, Pharmacy Revenue Specialists — Published February 28, 2026

2026 guide to compounding pharmacy valuation — EBITDA multiples, SDE analysis, what increases your multiple, prescriber concentration risk, compliance record impact, and exit readiness scoring.

Frequently Asked Questions

Why Most Pharmacy Owners Don't Know Their Number
The question "what is my pharmacy worth?" is one that most owners don't ask until they're planning to sell — and by then, it's often too late to optimize the answer. Pharmacy valuation is both a financial calculation and an operational assessment. Understanding how buyers evaluate pharmacies helps you build the right kind of business from day one — not just the most profitable business in the short term.
What Drives Your Multiple Down
- Over-reliance on a single compound category (e.g., 70% of revenue from GLP-1 compounding at a time when regulatory changes could restrict it) - Unresolved compliance issues or inspection findings - High owner dependency (pharmacy operations cannot function without the owner's direct daily involvement)
  1. SlimionRX
  2. Blog
  3. What Is Your Compounding Pharmacy Actually Worth? A 2026 Valuation Guide